Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics Revenue

In the year 2025, Arcutis Biotherapeutics had annual revenue of $376.07M with 91.34% growth. Arcutis Biotherapeutics had revenue of $129.50M in the quarter ending December 31, 2025, with 81.48% growth.

• Revenue (ttm): $376.07M
• Revenue Growth: +91.34%
• P/S Ratio: 7.81
• Revenue / Employee: $1,062,350
• Employees: 354
• Market Cap: 2.94B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	376.07M	179.53M	91.34%
Dec 31, 2024	196.54M	136.94M	229.74%
Dec 31, 2023	59.61M	55.92M	1,517.09%
Dec 31, 2022	3.69M	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 4, 2026

Data Sources Report a data error